News & Stories
BioSig Issues Shareholder Update to Highlight Recent Achievements and Ongoing Developments
To date, the Company's FDA 510(k)-cleared PURE EP' System has been used in approximately 3,000 patient cases across the United States
BioSig Executes Agreement with Bellin Health for the Acquisition of its PURE EP™ Technology
Leading Midwest healthcare system reports significant cost savings and noise reduction following evaluation of the PURE EP' System
Update: BioSig’s PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore
Abstract highlights promising results from PURE EP' study at premier Asia-Pacific Heart Rhythm Society Conference